EXACT Price To Sales Ratio from 2010 to 2025
| EXAS Stock | USD 51.74 1.30 2.58% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 6.13 | Current Value 5.82 | Quarterly Volatility 855.80737726 |
Check EXACT Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EXACT Sciences' main balance sheet or income statement drivers, such as Interest Expense of 29.5 M, Other Operating Expenses of 3.3 B or Research Development of 514.3 M, as well as many indicators such as Price To Sales Ratio of 5.82, Dividend Yield of 0.0 or PTB Ratio of 4.47. EXACT financial statements analysis is a perfect complement when working with EXACT Sciences Valuation or Volatility modules.
EXACT | Price To Sales Ratio |
Latest EXACT Sciences' Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of EXACT Sciences over the last few years. Price to Sales Ratio is figured by comparing EXACT Sciences stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on EXACT Sciences sales, a figure that is much harder to manipulate than other EXACT Sciences multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. EXACT Sciences' Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in EXACT Sciences' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 3.56 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
EXACT Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 320.44 | |
| Geometric Mean | 32.51 | |
| Coefficient Of Variation | 267.08 | |
| Mean Deviation | 488.61 | |
| Median | 16.97 | |
| Standard Deviation | 855.81 | |
| Sample Variance | 732,406 | |
| Range | 3.3K | |
| R-Value | (0.51) | |
| Mean Square Error | 576,885 | |
| R-Squared | 0.26 | |
| Significance | 0.04 | |
| Slope | (92.51) | |
| Total Sum of Squares | 11M |
EXACT Price To Sales Ratio History
About EXACT Sciences Financial Statements
EXACT Sciences shareholders use historical fundamental indicators, such as Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although EXACT Sciences investors may analyze each financial statement separately, they are all interrelated. The changes in EXACT Sciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on EXACT Sciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 6.13 | 5.82 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for EXACT Stock Analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.